Follow The Filings

TSHA position history

The shares of Taysha Gene Therapies (TSHA) that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.

Equity, COM SHS

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q4: 156,586 shares, $861K, <0.01% of portfolio, New
  2. 2026 Q1: 319,748 shares, $1.4M, <0.01% of portfolio, Add +104.2%
  3. 2026 Q2: 489,219 shares, $3.3M, 0.03% of portfolio, Add +53.0%
  4. 2026 Q3: 503,379 shares, $2.5M, 0.03% of portfolio, Add +2.9%
Holdings date Value % of holdings Shares Filing date All 13F holders